C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/02/2004	US6811999 Method for determining calciotropic activity of a preparation of Padina pavonica algae
11/02/2004	US6811997 Method for chromium analysis and speciation
11/02/2004	US6811994 Method for quantitating triglycerides in lipoproteins
11/02/2004	US6811993 Diagnostic and screening methods based on monocyte PKC activity
11/02/2004	US6811992 Mixed-lineage kinases (mlks); for preventing neurodegenerative diseases characterized by glutamine or kainate mediated toxicity (huntington's/alzheimer's disease); drug screening
11/02/2004	US6811991 Using apparatus for infrared quantitative analysis; reducing sugars in solution
11/02/2004	US6811990 Methods and compositions for coupled luminescent assays
11/02/2004	US6811986 5′-thio phosphate directed ligation of oligonucleotides and use in detection of single nucleotide polymorphisms
11/02/2004	US6811985 Oligonucleotides for use in diagnosis of cell proliferative disorders
11/02/2004	US6811984 Nucleotide sequences for detection of Bacillus anthracis
11/02/2004	US6811983 Detection of epstein bar virus modulator; obtain cells infected with epstein bar virus and control, expose to viricide, monitor apoptosis evaluate efficiency of viral modulator
11/02/2004	US6811982 Analysis of nucleotide sequence methylation patterns; obtain genomic nucleotide sequences, incubate with sodium bisulfite, expose to primers, amplify, isolate amplification products, determine concentration of alleles
11/02/2004	US6811981 Release of intracellular material
11/02/2004	US6811980 Fixing nucleotide sequences to solid support; obtain nucleotide sequences, incubate with oxygen chemical intermediate, monitor solid suport for presence of fixed nucleotide sequences
11/02/2004	US6811979 Fluorescent nucleobase conjugates having anionic linkers
11/02/2004	US6811978 Detection and identification of pseudomonas species using the 16S-23S rRNA spacer
11/02/2004	US6811977 Rapid, quantitative method for the mass spectrometric analysis of nucleic acids for gene expression and genotyping
11/02/2004	US6811976 Which encodes mitochondrial dna polmerase; microsatellite sequences
11/02/2004	US6811975 Phosphorothioate oligonucleotides having modified internucleoside linkages
11/02/2004	US6811974 Nuclelotide sequences for use in the detection of hepatitis virus
11/02/2004	US6811973 Methods of using labeled probe molecules to quantify target molecules
11/02/2004	US6811972 For preparing a hybridoma cell line which specifically recognizes and binds tumor associated antigen; antibodies; prostate carcinoma tumor antigen gene-1
11/02/2004	US6811971 Obtaining a saliva sample, preparing for detection and detecting
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004	US6811969 Retentate chromatography—profiling with biospecific interaction adsorbents
11/02/2004	US6811968 Method of monitoring cell motility and chemotaxis
11/02/2004	US6811967 Method for assaying non-spermine/spermidine activity of spermidine/spermine N1-acetyltransferase (SSAT)
11/02/2004	US6811966 Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
11/02/2004	US6811659 Contacting an electrode with a hanging drop of the solution to be plated (e.g. glucose oxidase) from a microdispenser, wherein the electrode is electrically coupled with the microdispenser; efficiency-low volume of solution used
11/02/2004	CA2176348C Hybridization probes for nucleic acid detection, universal stems, methods and kits
11/01/2004	CA2464874A1 Intraoperative lymph node assay
11/01/2004	CA2463716A1 Rapid extraction of rna from cells and tissues
10/2004
10/30/2004	CA2451291A1 Test tray and test system for determining response of a biological sample
10/30/2004	CA2428646A1 Array and uses thereof
10/28/2004	WO2004092740A2 Methods for identifying therapeutic targets involved in glucose and lipid metabolism
10/28/2004	WO2004092738A2 Assay for modulators of e2f-1 phosphorylation
10/28/2004	WO2004092734A2 Novel approach to molecular diagnosis of human papilloma virus-related diseases
10/28/2004	WO2004092733A1 Reduction of migration shift assay interference
10/28/2004	WO2004092731A1 Element having bioactive substance fixed thereto
10/28/2004	WO2004092728A2 Methods of measuring the ability of a test compound to inactivate a biological target in cells of a subject
10/28/2004	WO2004092720A1 Sensor-receiving container
10/28/2004	WO2004092708A2 Methods for the electrochemical detection of target compounds
10/28/2004	WO2004092420A1 Method and kit for molecular identification of smallpox
10/28/2004	WO2004092419A2 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same (i)
10/28/2004	WO2004092418A2 Global amplification using a randomly primed composite primer
10/28/2004	WO2004092417A2 Molecular correlates of cocaine addiction and methods for their use
10/28/2004	WO2004092416A1 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same
10/28/2004	WO2004092415A1 Method of detecting or quantitatively determining mitochondrial dna 3243 variation, and kit therefor
10/28/2004	WO2004092414A1 Method of calibration of reverse transcription using a synthetic messenger rna (smrna) as an internal control
10/28/2004	WO2004092413A2 High throughput functional genomic screening methods for osteoarthritis
10/28/2004	WO2004092412A2 Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup
10/28/2004	WO2004092411A1 Insulin-induced gene as therapeutic target in diabetes
10/28/2004	WO2004092410A2 Method for diagnosing rheumatoid arthritis or osteoarthritis
10/28/2004	WO2004092409A2 Novel genes involved in the escherichia coli biofilm formation and uses thereof
10/28/2004	WO2004092408A2 Oligonucleotides for the detection of salmonella species
10/28/2004	WO2004092407A1 Pygopus in diagnosis and treatment of cancer
10/28/2004	WO2004092406A1 Polynucleotides for the detection of listeria monocytogenes
10/28/2004	WO2004092405A2 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
10/28/2004	WO2004092404A2 Inhibitors of acidic mammalian chitinase as asthma therapeutics
10/28/2004	WO2004092402A1 Dual reporter/dye reduction methodology for evaluating antiviral activity and cytotoxicity of hepatitis c virus inhibitors
10/28/2004	WO2004092401A1 Method for the detection and/or identification of bacteria present in a sample
10/28/2004	WO2004092400A2 Medium for the detection and identification of micro-organisms
10/28/2004	WO2004092399A2 Real-time polmerase chain reaction-based genotyping assay for single nucleotide polymorphism
10/28/2004	WO2004092385A1 METHOD OF DETECTING β3 ADRENALINE RECEPTOR MUTANT GENE AND NUCLEIC ACID PROBE AND KIT THEREFOR
10/28/2004	WO2004092384A2 Means and methods for diagnosing and treating affective disorders
10/28/2004	WO2004092382A1 Method of detecting pancryatic islet amyloid protein mutant gene and nucleic acid probe and kit therefor
10/28/2004	WO2004092368A1 Method of examining obesity or emaciation
10/28/2004	WO2004092366A1 Mtehod of distinguishing ear shape and resistance against gibberella zeae and method of improving barley plant using the same
10/28/2004	WO2004092365A1 Method of extracting and selecting liver injury-associated gene group and method of evaluating and diagnosing liver injury or liver function using the same
10/28/2004	WO2004092360A2 The severe acute respiratory syndrome coronavirus
10/28/2004	WO2004092342A2 Lateral flow system for nucleic acid detection
10/28/2004	WO2004092341A2 Dual hybridization of complex nucleic acid samples for sequencing and single-nucleotide polymorphism identification
10/28/2004	WO2004092340A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
10/28/2004	WO2004092338A2 Compositions, splice variants and methods relating to cancer specific genes and proteins
10/28/2004	WO2004092331A2 Composition and method for nucleic acid sequencing
10/28/2004	WO2004092330A2 Method of generating long nucleic acid molecules of defined sequence
10/28/2004	WO2004092327A2 Method of generating size standard nucleic acids
10/28/2004	WO2004092325A2 Screening methods using zebrafish to identify thrombotic and anti-thrombotic compounds and genes
10/28/2004	WO2004092324A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
10/28/2004	WO2004092213A1 Gene expressed in prostate cancer, methods and use thereof
10/28/2004	WO2004092211A1 Non-fluorescent report protein activateable by proteolyse for fluorescence and the use thereof for detecting protease-depending events
10/28/2004	WO2004092200A2 Peptide substrate libraries
10/28/2004	WO2004092198A2 Compositions and methods for the modifying hypoxia induced gene regulation
10/28/2004	WO2004091548A2 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
10/28/2004	WO2004091526A2 Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies
10/28/2004	WO2004091523A2 Method for identifying ligands specific for structural isoforms of proteins
10/28/2004	WO2004091511A2 Compositions and methods to diagnose and treat lung cancer
10/28/2004	WO2004091505A2 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
10/28/2004	WO2004091481A2 Methods and kits for detecting cerebrospinal fluid in a sample
10/28/2004	WO2004091479A2 Gene amplification and overexpression in cancer
10/28/2004	WO2004091476A2 Method of screening remedy for heart disease and medicinal composition for treating heart disease
10/28/2004	WO2004091383A2 Breast endothelial cell expression patterns
10/28/2004	WO2004091376A2 Medical device for monitoring blood phenylalanine levels
10/28/2004	WO2004091372A2 Methods of assessing crohn’s disease patient phenotype by i2, ompc and asca serologic response
10/28/2004	WO2004081531A9 Ligand analysis
10/28/2004	WO2004076679A3 Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer
10/28/2004	WO2004072651A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f)
10/28/2004	WO2004065938A3 Human osteoporosis gene
10/28/2004	WO2004061074A3 Endometrial genes in endometrial disorders
10/28/2004	WO2004060832A3 Fluorescent creatinine assay

1 ... 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 ... 3003